Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEST Study: Early Screening Test for Pre-eclampsia and Growth Restriction
2013-004241-17Phase 4Completed
- Sponsor
- University College Dublin
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in preeclampsia and intrauterine growth restriction (IUGR) (2 arms), sponsored by University College Dublin. Primary endpoints: Rate of severe pre-eclampsia and Feasibility measures of early screening. Started Jan 2014; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2013-004241-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004241-17.